Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Seelos Therapeutics, Inc. (SEEL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.8421-0.0257 (-2.96%)
At close: 04:00PM EST
0.8600 +0.02 (+2.13%)
After hours: 06:16PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inside Bar (Bullish)

Inside Bar (Bullish)

Previous Close0.8678
Open0.8600
Bid0.8301 x 2200
Ask0.8810 x 1100
Day's Range0.8300 - 0.8998
52 Week Range0.4800 - 1.5200
Volume358,624
Avg. Volume637,677
Market Cap90.246M
Beta (5Y Monthly)1.96
PE Ratio (TTM)N/A
EPS (TTM)-0.6090
Earnings DateAug 05, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SEEL

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Seelos Therapeutics, Inc.
    Analyst Report: Eli Lilly and CompanyEli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
Advertisement
Advertisement